Huang Mingguo, Narita Shintaro, Inoue Takamitsu, Koizumi Atsushi, Saito Mitsuru, Tsuruta Hiroshi, Numakura Kazuyuki, Satoh Shigeru, Nanjo Hiroshi, Sasaki Takehiko, Habuchi Tomonori
Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo 102-0004, Japan.
Oncotarget. 2017 Dec 4;8(67):111780-111794. doi: 10.18632/oncotarget.22908. eCollection 2017 Dec 19.
Fatty acid binding protein 4 (FABP4) is an abundant protein in adipocytes, and its production is influenced by high-fat diet (HFD) or obesity. The prostate stromal microenvironment induces proinflammatory cytokine production, which is key for the development and progression of prostate cancer (PCa). Here, we show that high FABP4 expression and its secretion by PCa cells directly stimulated PCa cell invasiveness by upregulating matrix metalloproteinases through phosphatidylinositol 3-kinase and mitogen-activated protein kinase signaling pathways. In addition, prostate stromal cells augmented PCa cell invasiveness by secreting interleukin-8 and -6 in response to FABP4. This was abrogated by the FABP4 specific inhibitor, BMS309403. Furthermore, a mouse xenograft experiment showed HFD enhanced PCa metastasis and invasiveness by the upregulation of FABP4 and interleukin-8. Clinically, the serum level of FABP4 was significantly associated with an aggressive type of PCa rather than obesity. Taken together, FABP4 may enhance PCa progression and invasiveness by upregulating matrix metalloproteinases and cytokine production in the PCa stromal microenvironment, especially under HFD or obesity.
脂肪酸结合蛋白4(FABP4)是脂肪细胞中一种丰富的蛋白质,其产生受高脂饮食(HFD)或肥胖的影响。前列腺基质微环境可诱导促炎细胞因子的产生,这是前列腺癌(PCa)发生和进展的关键。在此,我们表明PCa细胞中高表达的FABP4及其分泌通过磷脂酰肌醇3激酶和丝裂原活化蛋白激酶信号通路上调基质金属蛋白酶,直接刺激PCa细胞的侵袭性。此外,前列腺基质细胞通过分泌白细胞介素-8和-6对FABP4作出反应,增强了PCa细胞的侵袭性。FABP4特异性抑制剂BMS309403可消除这种作用。此外,一项小鼠异种移植实验表明,HFD通过上调FABP4和白细胞介素-8增强了PCa的转移和侵袭性。临床上,FABP4的血清水平与侵袭性PCa类型显著相关,而非与肥胖相关。综上所述,FABP4可能通过上调PCa基质微环境中的基质金属蛋白酶和细胞因子产生来增强PCa的进展和侵袭性,尤其是在HFD或肥胖情况下。